Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and long term risks of the new companies….. A full-service firm!
This past week three IPOs debuted…all with strong performances at the open. No other was strong than the first unicorn IPO of the year, ZScaler Inc.
ZScaler Inc (ZS) upsized and boosted the range from an original 10mm shares at $10-$12 to 12mm shares at $13-$15. Ultimately, ZScaler (2018’s first unicorn), priced 12.0mm shares at $16.00 and opened at $27.50- for a spectacular debut.
Arcus Biosciences (RCUS) upsized its offering and priced at the high-end of the $13-$15 range. RCUS opened with a 33% premium with a first trade of $20.00 but sold off in its opening session…closing its first day as a publicly traded company at $17.00.
Bridgewater Bancshares (BWB) priced its offering at the midpoint of the $10.50-$12.50 range, $11.75, and opened to a 7.7% premium with a $12.66 first trade. BWB traded above $13.00 in its opening session’s marking another win for Sandler O’Neill as a bank holding company underwriter.
Looking ahead to this week, there are three IPOs on the schedule. Click on the image below to read a preview of each deal.